In the high-stakes world of biotech investment, portfolio diversification has emerged as a critical strategy for safeguarding returns and mitigating risk. This practice, which involves balancing a blend of assets including bonds, alternative investments, gold, securities across various regions, and now, more recently, exchange-traded and mutual funds, has been significantly influenced by the changing dynamics […]